Latest stories on DNTH
DNTH Initiated Coverage by Roth Capital -- Rating Set to Buy
GuruFocus63 · neutralanalyst
Roth/MKM initiates Dianthus Therapeutics stock at buy on drug profile
Investing.com Analyst Ratings63 · neutralanalyst
Why is Dianthus Therapeutics stock gaining today?
Investing.com Markets63 · neutralgeneral
Dianthus initiated with a Buy at Roth Capital
The Fly63 · neutralanalyst
Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
Business Insider58 · neutralproduct/pr
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
William Blair refreshes its analyst conviction list
Seeking Alpha57 · neutralanalyst
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
StockTitan63 · neutralproduct/pr
Dianthus files automatic mixed securities shelf
The Fly42 · neutralgeneral
Dianthus participates in a conference call with JPMorgan
The Fly55 · neutralgeneral
Dianthus initiated with an Overweight at JPMorgan
The Fly63 · neutralanalyst
JPMorgan initiates Dianthus stock at Overweight, $135 target
Investing.com Analyst Ratings61 · neutralanalyst
Dianthus Therapeutics, Inc. (DNTH) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Seeking Alpha56 · neutralgeneral
Dianthus: Hold, Based On Competitor C1s' CIDP Setback And Continued Claseprubart Advancement
Seeking Alpha48 · neutralanalyst
Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen
Yahoo Finance58 · neutralearnings
Dianthus gains new Buy from Citi on multi-blockbuster potential for lead drug
Seeking Alpha61 · neutralanalyst
Dianthus initiated with a Buy at Citi
The Fly61 · neutralanalyst
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Dianthus Therapeutics to Participate in Three Investor Conferences During September
Business Insider56 · neutralgeneral
Dianthus Therapeutics to Participate in Three Investor Conferences During September
GlobeNewswire56 · neutralgeneral
Dianthus Therapeutics: The C1s Shakeout Strengthens The Bull Case
Seeking Alpha67 · bullishproduct/pr
Dick’s Sporting Goods shares rise after Wells Fargo upgrade
InvestorsHub61 · neutralanalyst
Raymond James raises Dianthus Therapeutics price target on new asset
Investing.com Analyst Ratings61 · neutralanalyst